ORAL MANIFESTATIONS ASSOCIATED WITH ANTIDEPRESSANT USE AND THEIR SIGNIFICANCE IN DENTAL PRACTICE: A NARRATIVE LITERATURE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6336Keywords:
Antidepressants, Oral Manifestations, Xerostomia, Hyposalivation, Adverse Drug Reactions, Dental PracticeAbstract
Antidepressants are widely used in the treatment of depressive disorders; therefore, dentists increasingly encounter patients receiving such pharmacotherapy. In addition to their therapeutic benefits, these drugs may cause adverse effects that manifest within the oral cavity and influence both oral health status and the course of dental treatment.
The aim of this paper was to present the current state of knowledge regarding oral manifestations associated with antidepressant use and to discuss their significance in everyday dental practice. This article is a narrative literature review based on scientific publications concerning the effects of antidepressants on oral tissues.
The analysis showed that the most frequently described adverse effects are xerostomia and hyposalivation, which play an important role in the development of secondary complications, such as increased risk of dental caries, oral mucosal discomfort, and opportunistic infections. The literature also reports possible bruxism, taste disorders, and complex associations between depression, pharmacotherapy, and periodontal diseases. Available evidence indicates that oral changes usually result from the interaction of pharmacotherapy, the course of depression itself, and individual risk factors.
Early identification of adverse effects, appropriate preventive care, and interdisciplinary cooperation between the dentist and the physician managing psychiatric treatment may reduce the risk of complications and improve the quality of care for patients using antidepressants.
References
Alcázar-Hernández, J. M., Pecci-Lloret, M. R., & Guerrero-Gironés, J. (2024). Oral manifestations in patients in treatment with antidepressants: A systematic review. Journal of Clinical Medicine, 13(22), Article 6945. https://doi.org/10.3390/jcm13226945
Cockburn, N., Pradhan, A., Taing, M. W., Kisely, S., & Ford, P. J. (2017). Oral health impacts of medications used to treat mental illness. Journal of Affective Disorders, 223, 184–193. https://doi.org/10.1016/j.jad.2017.07.037
Daly, C. G. (2016). Oral and dental effects of antidepressants. Australian Prescriber, 39(3), 84. https://doi.org/10.18773/austprescr.2016.035
Fasipe, O. J. (2018). Neuropharmacological classification of antidepressant agents based on their mechanisms of action. Archives of Medicine and Health Sciences, 6(1), 81–94. https://doi.org/10.4103/amhs.amhs_7_18
Felipe, L. O. (2024). Dental management in the face of oral manifestations in patients who make chronic use of antidepressants: A literature review. In Science and connections: The interdependence of disciplines (pp. 1198–1201). Seven Editora. https://doi.org/10.56238/sevened2024.037-075
Garrett, A. R., & Hawley, J. S. (2018). SSRI-associated bruxism: A systematic review of published case reports. Neurology: Clinical Practice, 8(2), 135–141. https://doi.org/10.1212/CPJ.0000000000000433
Glick, A., Sista, V., & Johnson, C. (2020). Oral manifestations of commonly prescribed drugs. American Family Physician, 102(10), 613–621. https://www.aafp.org/afp/2020/1115/p613
Kharat, A., Baidya, O. P., Choudhari, S. H., Shakeela, N. V., Nasim, R., & Hathi, K. (2025). Impact of systemic medications on oral health: A cross-sectional study among geriatric patients. Cureus, 17(7), Article e88964. https://doi.org/10.7759/cureus.88964
Kovich, H., Kim, W., & Quaste, A. M. (2023). Pharmacologic treatment of depression. American Family Physician, 107(2), 173–181. https://www.aafp.org/afp/2023/0200/pharmacologic-treatment-of-depression
Lobbezoo, F., Ahlberg, J., Raphael, K. G., Wetselaar, P., Glaros, A. G., Kato, T., Santiago, V., Winocur, E., De Laat, A., De Leeuw, R., Koyano, K., Lavigne, G. J., Svensson, P., & Manfredini, D. (2018). International consensus on the assessment of bruxism: Report of a work in progress. Journal of Oral Rehabilitation, 45(11), 837–844. https://doi.org/10.1111/joor.12663
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE Guideline NG222). https://www.nice.org.uk/guidance/ng222
Rademacher, W. M. H., Aziz, Y., Hielema, A., Cheung, K.-C., de Lange, J., Vissink, A., & Rozema, F. R. (2020). Oral adverse effects of drugs: Taste disorders. Oral Diseases, 26(1), 213–223. https://doi.org/10.1111/odi.13199
Taccardi, D., Chiesa, A., Maiorani, C., Pardo, A., Lombardo, G., Scribante, A., Sabatini, S., & Butera, A. (2024). Periodontitis and depressive disorders: The effects of antidepressant drugs on the periodontium in clinical and preclinical models: A narrative review. Journal of Clinical Medicine, 13(15), Article 4524. https://doi.org/10.3390/jcm13154524
Teoh, C. X. W., Thng, M., Lau, S., Taing, M.-W., Chaw, S. Y., Siskind, D., & Kisely, S. (2023). Dry mouth effects from drugs used for depression, anxiety, schizophrenia and bipolar mood disorder in adults: Systematic review. BJPsych Open, 9(2), Article e53. https://doi.org/10.1192/bjo.2023.15
Teoh, L., Moses, G., & McCullough, M. J. (2019a). A review and guide to drug-associated oral adverse effects—Dental, salivary and neurosensory reactions. Part 1. Journal of Oral Pathology & Medicine, 48(7), 626–636. https://doi.org/10.1111/jop.12911
Teoh, L., Moses, G., & McCullough, M. J. (2019b). A review and guide to drug-associated oral adverse effects—Oral mucosal and lichenoid reactions. Part 2. Journal of Oral Pathology & Medicine, 48(7), 637–646. https://doi.org/10.1111/jop.12910
Villa, A., Connell, C. L., & Abati, S. (2015). Diagnosis and management of xerostomia and hyposalivation. Therapeutics and Clinical Risk Management, 11, 45–51. https://doi.org/10.2147/TCRM.S76282
Wolff, A., Joshi, R. K., Ekström, J., Aframian, D., Pedersen, A. M. L., Proctor, G., Narayana, N., Villa, A., Sia, Y. W., Aliko, A., McGowan, R., Kerr, A. R., Jensen, S. B., Vissink, A., & Dawes, C. (2017). A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: A systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D, 17(1), 1–28. https://doi.org/10.1007/s40268-016-0153-9
World Health Organization. (2025, August 29). Depressive disorder (depression). https://www.who.int/news-room/fact-sheets/detail/depression
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Malgorzata Berowska, Agnieszka Ciepiela, Zuzanna Kucia, Jakub Sagan, Gabriela Pilch, Michał Zemowski, Ewa Berowska-Skórka
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
